Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Presence or severity of Hashimoto’s thyroiditis does not influence basal calcitonin levels: observations from CROHT biobank (CROSBI ID 304195)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Cvek, M. ; Punda, A. ; Brekalo, M. ; Plosnić, M. ; Barić, A. ; Kaličanin, D. ; Brčić, L. ; Vuletić, M. ; Gunjača, I. ; Torlak Lovrić, V. et al. Presence or severity of Hashimoto’s thyroiditis does not influence basal calcitonin levels: observations from CROHT biobank // Journal of endocrinological investigation, 10.1007 (2021), 10.1007/s40618-021-01685-3, 9. doi: 10.1007/s40618-021-01685-3

Podaci o odgovornosti

Cvek, M. ; Punda, A. ; Brekalo, M. ; Plosnić, M. ; Barić, A. ; Kaličanin, D. ; Brčić, L. ; Vuletić, M. ; Gunjača, I. ; Torlak Lovrić, V. ; Škrabić, V. ; Boraska Perica, V.

engleski

Presence or severity of Hashimoto’s thyroiditis does not influence basal calcitonin levels: observations from CROHT biobank

Purpose: The influence of Hashimoto's thyroiditis (HT) on calcitonin (Ct) production is unresolved question. The aim of this study was to explore if basal Ct levels are influenced by the presence/severity of HT or correlated with clinical phenotypes of HT patients. Methods: We included 467 HT patients and 184 control participants, from Croatian Biobank of HT patients (CROHT), in this retrospective study. Calcitonin levels between HT patients and controls were compared using Mann-Whitney test. Ct levels between two subgroups of HT patients, divided by intake of levothyroxine (LT4) therapy, were additionally tested to take into account the illness severity. Spearman rank correlation test was used to analyze correlations between Ct levels and 14 relevant phenotypes. Results: We have not detected significant differences in median Ct levels between HT patients and controls (2.2 vs 2.35 pg/mL, respectively, P = 0.717) nor in-between two subgroups of HT patients (P = 0.347). We have not detected statistically significant correlations between Ct levels and clinical phenotypes, although we identified three weak nominal correlations: negative correlation of Ct with TgAb in all HT patients (r = - 0.1, P = 0.04) ; negative correlation of Ct with age in subgroup of HT patients without LT4 therapy (r = - 0.13, P = 0.04) ; positive correlation of Ct with BSA in subgroup of HT patients on LT4 therapy (r = 0.16, P = 0.042). Conclusion: Our results suggest that HT patients of all disease stages preserve Ct production as healthy individuals and there is no need for Ct measurements in the absence of a nodule. Additional confirmation and clarification of observed nominal correlations are needed due to potential clinical relevance of TgAb and age- dependent Ct decrease in HT women.

Calcitonin ; Hashimoto's thyroiditis ; Thyroid autoimmunity ; Thyroglobulin antibody (TgAb) ; Age ; BSA

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

10.1007

2021.

10.1007/s40618-021-01685-3

9

objavljeno

0391-4097

1720-8386

10.1007/s40618-021-01685-3

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost